inspirator schreef op 4 mei 2015 08:05:
MDxHealth: Exploiting A Valuation Anomaly Between Exact Sciences And Their European Licensor
MDXH should be worth at least 15.25 Euros a share compared to the current share price of 5 Euros a share and maybe much more over time. Biotech and smaller healthcare companies in Europe are often cheaper than their US equivalents.